isotretinoin and Anemia--Refractory--with-Excess-of-Blasts

isotretinoin has been researched along with Anemia--Refractory--with-Excess-of-Blasts* in 1 studies

Trials

1 trial(s) available for isotretinoin and Anemia--Refractory--with-Excess-of-Blasts

Article	Year
[Refractory anemia with partial blastosis. A new therapeutic approach]. Presse medicale (Paris, France : 1983), 1989, Jun-10, Volume: 18, Issue:23 Refractory anaemia with partial myeloblastosis is classified among myelodysplasia syndromes which are characterized by abnormalities in the differentiation of haematopoietic cells, but it differs from these syndromes in that blast cells are in excess and the prognosis is darker. So far, this type of anaemia has resisted all treatment. The possibility of differentiating leukaemic cells in vitro has opened new therapeutic prospects. Topics: Aclarubicin; Anemia, Refractory, with Excess of Blasts; Cholecalciferol; Clinical Trials as Topic; Colony-Stimulating Factors; Cytarabine; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Humans; Interferons; Isotretinoin; Prognosis; Remission Induction	1989

Article

Year

[Refractory anemia with partial blastosis. A new therapeutic approach].

Presse medicale (Paris, France : 1983), 1989, Jun-10, Volume: 18, Issue:23

Refractory anaemia with partial myeloblastosis is classified among myelodysplasia syndromes which are characterized by abnormalities in the differentiation of haematopoietic cells, but it differs from these syndromes in that blast cells are in excess and the prognosis is darker. So far, this type of anaemia has resisted all treatment. The possibility of differentiating leukaemic cells in vitro has opened new therapeutic prospects.

Topics: Aclarubicin; Anemia, Refractory, with Excess of Blasts; Cholecalciferol; Clinical Trials as Topic; Colony-Stimulating Factors; Cytarabine; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Humans; Interferons; Isotretinoin; Prognosis; Remission Induction

1989